For the first time, the people dimension of your portfolio has an instrument.
Request a Diagnostic → See What the Board Sees →You stress-test financials, technology, and market position. The people architecture that determines whether the thesis executes is assessed through interviews and intuition - not from negligence, but from the absence of an instrument.
NexStep is that instrument. A structured people dimension added to the investment thesis. Governance-grade evidence where previously only qualitative judgment existed.
Capital has been deployed, but whether the people architecture is ready to absorb it and operate at scale remains unclear.
The organisation is transitioning beyond founder-led execution, but the structure required to support that shift has not been assessed.
Financial and operating performance are tracked, but there is no consistent, comparable view of people architecture across the portfolio.
The thesis is defined and execution is underway, but the organisation's ability to deliver at scale remains unverified.
Structural risk that does not surface in financial diligence becomes visible.
Capital deployment is supported by operating architecture capable of absorbing and executing against it.
The people dimension becomes a measurable variable, not an inferred one.
Judgment shifts from conversation-led assessment to evidence-backed evaluation.
Comparability across portfolio companies replaces fragmented interpretation.
Operational value becomes demonstrable at the fund level, including to LPs.
The first step is a structured conversation to determine fit - yours and ours.
Founding Launch engagement terms, including a complimentary Diagnose tier, remain available until 31st May 2026.
Request a Diagnostic → See What the Board Sees →